US Stock MarketDetailed Quotes
VOR Vor Biopharma
- 0.908
- +0.083+10.06%
Close Sep 6 16:00 ET
- 0.900
- -0.008-0.87%
Post 19:59 ET
62.11MMarket Cap-524P/E (TTM)
1.160High0.870Low21.34MVolume0.959Open0.825Pre Close21.44MTurnover66.58%Turnover RatioLossP/E (Static)68.40MShares3.14052wk High0.63P/B29.10MFloat Cap0.70052wk Low--Dividend TTM32.05MShs Float63.620Historical High--Div YieldTTM35.15%Amplitude0.700Historical Low1.004Avg Price1Lot Size
Vor Biopharma Key Stats
Quarterly+Annual
YOY
| (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 9.35%-21.85M | -25.54%-30.47M | -17.79%-100.29M | -30.96%-24.03M | -47.59%-27.9M | 3.57%-24.1M | -5.96%-24.27M | -23.14%-85.14M | -4.32%-18.35M | -8.99%-18.9M |
| Net income from continuing operations | 7.14%-27.84M | -8.34%-30.8M | -27.98%-117.86M | -9.83%-26.26M | -39.52%-33.19M | -38.41%-29.98M | -25.05%-28.43M | -33.67%-92.09M | -31.00%-23.91M | -28.21%-23.79M |
| Depreciation and amortization | -0.11%869K | 12.66%943K | 38.30%3.49M | 41.14%892K | 313.13%893K | -53.87%870K | 96.48%837K | 76.08%2.53M | 60.00%632K | -212.03%-419K |
| Other non cash items | 6.20%1.25M | 8.17%1.23M | 32.11%4.73M | 407.05%4.89M | ---2.48M | --1.18M | 23.80%1.14M | 12.13%3.58M | 7.95%964K | ---- |
| Change In working capital | 68.02%1.41M | -508.57%-4.12M | 106.61%650K | -871.29%-779K | 344.79%1.27M | 113.75%838K | 79.63%-677K | -7.09%-9.84M | 105.53%101K | 53.21%-518K |
| -Change in prepaid assets | -99.09%20K | -10,242.86%-710K | 1,353.33%3.27M | 882.42%712K | -67.05%344K | 118.08%2.21M | 100.40%7K | 103.54%225K | 88.98%-91K | 170.88%1.04M |
| -Change in payables and accrued expense | 414.95%551K | -2,720.45%-2.48M | 155.83%2.85M | -89.61%172K | 185.61%2.66M | 114.25%107K | 87.81%-88K | 175.06%1.11M | 2,200.00%1.66M | -14.98%931K |
| -Change in other current assets | 468.13%1.76M | -105.22%-7K | -161.72%-1.89M | -1,444.68%-726K | -65.92%-818K | -936.96%-477K | 199.26%134K | -7.93%-721K | 86.69%-47K | -1,543.33%-493K |
| -Change in other current liabilities | 8.01%-919K | -26.16%-921K | 65.73%-3.58M | 33.87%-937K | 54.15%-917K | 84.17%-999K | -0.41%-730K | -308.52%-10.45M | -97.08%-1.42M | -186.12%-2M |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 9.35%-21.85M | -25.54%-30.47M | -17.79%-100.29M | -30.96%-24.03M | -47.59%-27.9M | 3.57%-24.1M | -5.96%-24.27M | -23.14%-85.14M | -4.32%-18.35M | -8.99%-18.9M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 288.52%52.99M | 576.72%43.97M | 175.47%71.01M | 110.65%10.34M | 219.13%40.54M | 604.77%13.64M | 192.10%6.5M | -2.66%-94.09M | -1,530.04%-97.04M | 249.68%12.7M |
| Net PPE purchase and sale | 97.74%-9K | -21.28%-114K | 87.37%-1.07M | 65.42%-111K | -56.04%-465K | 93.16%-399K | 95.33%-94K | -117.31%-8.46M | 72.52%-321K | 53.14%-298K |
| Net investment purchase and sale | 277.54%53M | 568.80%44.09M | 184.17%72.08M | 110.80%10.45M | 215.39%41M | 348.50%14.04M | 230.69%6.59M | 2.42%-85.63M | -1,921.21%-96.72M | 265.61%13M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 288.52%52.99M | 576.72%43.97M | 175.47%71.01M | 110.65%10.34M | 219.13%40.54M | 604.77%13.64M | 192.10%6.5M | -2.66%-94.09M | -1,530.04%-97.04M | 249.68%12.7M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -114.22%-31K | -96.19%96K | -97.49%2.94M | -99.98%25K | -95.68%176K | -63.91%218K | 1,159.50%2.52M | -49.71%117.14M | 36,467.10%112.26M | 1,927.36%4.08M |
| Net common stock issuance | -115.89%-92K | -92.32%278K | -96.05%4.58M | -100.01%-15K | -89.79%392K | 14.88%579K | --3.62M | -38.70%115.98M | 11,163,100.00%111.63M | --3.84M |
| Proceeds from stock option exercised by employees | 116.90%61K | 52.85%-182K | -179.23%-923K | -93.66%40K | -192.31%-216K | -461.00%-361K | -293.00%-386K | 110.67%1.17M | 104.87%631K | 16.42%234K |
| Net other financing activities | ---- | ---- | ---717K | --0 | --0 | --0 | ---717K | ---- | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -114.22%-31K | -96.19%96K | -97.49%2.94M | -99.98%25K | -95.68%176K | -63.91%218K | 1,159.50%2.52M | -49.71%117.14M | 36,467.10%112.26M | 1,927.36%4.08M |
| Net cash flow | ||||||||||
| Beginning cash position | 5.59%47.38M | -43.82%33.77M | -50.81%60.12M | -24.99%47.44M | -47.03%34.63M | --44.87M | -50.81%60.12M | 143.95%122.21M | -56.52%63.24M | -61.79%65.37M |
| Current changes in cash | 403.74%31.11M | 189.20%13.6M | 57.57%-26.35M | -337.87%-13.67M | 703.01%12.81M | ---10.24M | ---15.25M | -186.10%-62.1M | 86.57%-3.12M | 91.71%-2.13M |
| End cash Position | 126.68%78.49M | 5.59%47.38M | -43.82%33.77M | -43.82%33.77M | -24.99%47.44M | --34.63M | --44.87M | -50.81%60.12M | -50.81%60.12M | -56.52%63.24M |
| Free cash flow | 10.79%-21.86M | -25.52%-30.58M | -8.28%-101.36M | -29.30%-24.14M | -47.72%-28.36M | 20.52%-24.5M | 2.22%-24.36M | -28.16%-93.61M | 0.47%-18.67M | -6.79%-19.2M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Audit Opinions | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
